The regulation and inhibition of the IL-6/JAK2/STAT3 pathway is conducive to cancer prevention and treatment as well as improved prognosis and, therefore, represents an important target for designing anti-cancer drugs [46, 47]. Here, JAK2 is linked to cancer.